Khairy: Malaysia, Merck sign agreement for Covid-19 drug Molnupiravir

PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

Health Minister Khairy Jamaluddin said the government signed a letter of undertaking on Thursday (Oct 7) to procure 150,000 courses of Molnupiravir to treat Covid-19 patients.

"This decision was made in preparation for Malaysia's move into the endemic phase and living with the Covid-19 virus. This is another "weapon" of choice to fight the coronavirus, besides the use of vaccines and other public health measures,” said Khairy in a statement.

Khairy said research conducted by Merck Sharp & Dohme found that Molnupiravir is able to reduce 50% of hospital admissions and is also effective towards more infectious variants of Covid-19 including Gamma, Delta and Mu.

The minister however stressed that Molnupiravir does not prevent infection and is only beneficial for people who have been infected by Covid-19.

He added that vaccines are still vital in the fight against Covid-19.

"Even though Molnupiravir is an effective medicine, it does not mean that vaccines are no longer needed. The purpose of vaccines is to reduce the chance of being infected and also to avoid severe infection," he said.

"We need both methods to reduce the burden of the Covid-19 disease and at the same time provide a bigger impact in our efforts to prevent and control the transmission of the virus," added Khairy.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Nation

Sabah ready for improved ties with Indonesia after new capital named
It's an old photo of approved logging, Forestry Dept says of claims regarding Perak forest reserve
Human rights legislation must be in line with nation's Constitution and composition, says Wan Junaidi
Saratok longhouse residents praised for putting out fire
PJ police probing claims of SOP breaches at product launch ceremony
SC cannot confirm if Azam Baki breached trading regulations
Company director jailed 15 years for cheating six contractors
Covid-19: Israeli study shows fourth vaccine shot less effective against Omicron variant
Sabah to probe citizenship claims of GLC board member, says Hajiji
PSC meeting should go on with or without Azam, say Opposition reps on committee

Others Also Read